Pharmacokinetics of Tazarotene Cream 0.1% After a Single Dose and After Repeat Topical Applications at Clinical or Exaggerated Application Rates in Patients with Acne Vulgaris or Photodamaged Skin

Author： Yu Z.   Sefton J.   Lew-Kaya D.A.   Walker P.S.   Yu D.   Tang-Liu D.D-S.  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.42, Iss.10, 2003-01, pp. : 921-929

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Pharmacokinetics and Drug Metabolism of Tazarotene: A Novel Topical Treatment for Acne and Psoriasis

By Tang-Liu D.-S.   Matsumoto R.M.   Usansky J.I.  

Clinical Pharmacokinetics, Vol. 37, Iss. 4, 1999-10 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

Topical tazarotene cream tops tretinoin in facial acne

By  

Inpharma, Vol. 1, Iss. 1304, 2001-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Tazarotene the clear winner for acne vulgaris

By  

Inpharma, Vol. 1, Iss. 1427, 2004-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Tazarotene the clear winner for acne vulgaris

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 448, 2004-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Tazarotene cream superior to adapalene in acne treatment

By  

Inpharma, Vol. 1, Iss. 1383-1384, 2003-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite